Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

897
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
897
Introduction to Epidemiology01:26

Introduction to Epidemiology

2.3K
Epidemiology, known as the cornerstone of public health, involves studying the distribution and determinants of health-related events in defined populations and applying these insights to control health issues. This is essential for understanding how diseases spread, identifying populations at greater risk, and implementing measures to control or prevent outbreaks. Epidemiology addresses not only infectious diseases but also non-communicable conditions like cancer and cardiovascular disease,...
2.3K
Pharmacokinetic–Pharmacodynamic Relationship: Problems01:24

Pharmacokinetic–Pharmacodynamic Relationship: Problems

65
The empirical approach to drug therapy optimization relies on correlating pharmacological response with administered dosage. Such an approach can be costly, time-consuming, and often yields poor correlation due to variables like formulation factors and drug elimination characteristics. A more precise approach correlates response with plasma drug concentration or the amount of drug in the body, rather than dosage. This is achieved through pharmacokinetic-pharmacodynamic (PK/PD) modeling, which...
65
Pharmacokinetic–Pharmacodynamic Relationship: Exposure, Response and Effect01:26

Pharmacokinetic–Pharmacodynamic Relationship: Exposure, Response and Effect

147
The pharmacokinetic-pharmacodynamic (PK-PD) relationship describes the intricate link between drug exposure, efficacy, and toxicity, forming the foundation for optimal dosing regimens. This relationship uses mathematical modeling to characterize drug concentration-effect dynamics, ensuring precise therapeutic outcomes.Exposure represents the pharmacokinetic aspect of the PK-PD relationship, denoting the drug amount that elicits a biological response. It is typically quantified by administered...
147
Pharmacovigilance01:19

Pharmacovigilance

1.9K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.9K
Measurement of Bioavailability: Pharmacodynamic Methods01:20

Measurement of Bioavailability: Pharmacodynamic Methods

939
Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
939

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Barriers for Access to New Medicines: Searching for the Balance Between Rising Costs and Limited Budgets.

Frontiers in public health·2018
Same author

Workshop on the Italian Pharmacovigilance System in the International Context: Critical Issues and Perspectives.

Drug safety·2018
Same author

Gabapentin and Pregabalin and Risk of Atrial Fibrillation in the Elderly: A Population-Based Cohort Study in an Electronic Prescription Database.

Drug safety·2018
Same author

Prevalence of use of antipsychotic drugs in the elderly in Catalonia.

European journal of clinical pharmacology·2018
Same author

Adaptive Pathways: Possible Next Steps for Payers in Preparation for Their Potential Implementation.

Frontiers in pharmacology·2017
Same author

Payers' Views of the Changes Arising through the Possible Adoption of Adaptive Pathways.

Frontiers in pharmacology·2016

Related Experiment Video

Updated: Mar 17, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.3K

[Pharmacoepidemiology: lights and shadows].

Joan-ramon Laporte, Eduardo Diogene

    Bulletin De L'Academie Nationale De Medecine
    |August 2, 2016
    PubMed
    Summary

    Adverse drug reactions pose a significant public health threat. Pharmacoepidemiology, through its evolving generations, aims to improve drug safety and reduce harm from medications.

    Area of Science:

    • Pharmacovigilance
    • Public Health
    • Epidemiology

    Context:

    • Adverse drug reactions (ADRs) are a leading cause of morbidity and mortality.
    • ADRs account for 5-10% of general practice consultations and hospital admissions.
    • ADRs represent a critical failure in contemporary medicine.

    Purpose:

    • To study drug use in populations and its impact on public health.
    • To describe the historical evolution of pharmacovigilance.
    • To highlight the role of pharmacoepidemiology in enhancing drug safety.

    Summary:

    • The history of pharmacovigilance is divided into four stages.
    • Spontaneous reporting identified ADRs but lacked incidence and risk data.
    • Second-generation pharmacovigilance utilizes observational epidemiological research for risk estimation.

    More Related Videos

    Author Spotlight: Exploring ShiDuGao's Multi-Target Approach in Anus Eczema Treatment
    12:34

    Author Spotlight: Exploring ShiDuGao's Multi-Target Approach in Anus Eczema Treatment

    Published on: January 12, 2024

    1.3K
    A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
    09:17

    A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

    Published on: January 2, 2017

    15.3K

    Related Experiment Videos

    Last Updated: Mar 17, 2026

    Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
    05:10

    Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

    Published on: December 11, 2016

    10.3K
    Author Spotlight: Exploring ShiDuGao's Multi-Target Approach in Anus Eczema Treatment
    12:34

    Author Spotlight: Exploring ShiDuGao's Multi-Target Approach in Anus Eczema Treatment

    Published on: January 12, 2024

    1.3K
    A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
    09:17

    A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

    Published on: January 2, 2017

    15.3K
  • Third-generation pharmacovigilance involves meta-analysis of clinical trials.
  • Fourth-generation pharmacovigilance is expected to leverage big data.

    • Impact:

    • Improved understanding of ADRs and their public health impact.
    • Enhanced ability to estimate incidence and risks associated with drug use.
    • Foundation for evidence-based public health decision-making regarding medications.
    • Future advancements in drug safety surveillance through big data analytics.